Q3 2016 13F Holders as of 30 Sep 2016
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share (the "Shares")
-
Shares outstanding
-
274M
-
Number of holders
-
198
-
Total 13F shares, excl. options
-
220M
-
Shares change
-
+29.8M
-
Total reported value, excl. options
-
$2.81B
-
Value change
-
+$415M
-
Put/Call ratio
-
0.58
-
Number of buys
-
134
-
Number of sells
-
-62
-
Price
-
$12.79
Significant Holders of EXELIXIS, INC. - Common Stock, par value $0.001 per share (the "Shares") (EXEL) as of Q3 2016
250 filings reported holding EXEL - EXELIXIS, INC. - Common Stock, par value $0.001 per share (the "Shares") as of Q3 2016.
EXELIXIS, INC. - Common Stock, par value $0.001 per share (the "Shares") (EXEL) has 198 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 220M shares
of 274M outstanding shares and own 80.1% of the company stock.
Largest 10 shareholders include FMR LLC (34.5M shares), Meditor Group Ltd (22.1M shares), VANGUARD GROUP INC (17.3M shares), PRICE T ROWE ASSOCIATES INC /MD/ (12.7M shares), BlackRock Fund Advisors (9.66M shares), STATE STREET CORP (8.56M shares), Invesco Ltd. (7.53M shares), GOLDMAN SACHS GROUP INC (7.16M shares), ORBIMED ADVISORS LLC (6.21M shares), and LORD, ABBETT & CO. LLC (5.97M shares).
This table shows the top 198 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.